FR Doc E8-28756[Federal Register: December 5, 2008 (Volume
73, Number 235)] [Notices] [Page 74194-74195] From the Federal
Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05de08-101]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21
U.S.C. 958(i), the Attorney General shall, prior to issuing
a registration under this Section to a bulk manufacturer of a
controlled substance in schedule I or II, and prior to issuing a
regulation under 21 U.S.C. 952(a)(2) authorizing the importation
of such a substance, provide manufacturers holding registrations
for the bulk manufacture of the substance an opportunity for a
hearing.
Therefore, in accordance with Title 21 Code of Federal
Regulations (CFR),
1301.34(a), this is notice that on July 15, 2008, Cerilliant
Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas
78665-2402, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as an importer of the
basic classes of controlled substances listed in schedules I and
II:
|
Drug
|
Schedule
|
|
Cathinone (1235)
|
I
|
|
Methcathinone (1237)
|
I
|
|
N-Ethylamphetamine (1475)
|
I
|
|
N,N-Dimethylamphetamine (1480)
|
I
|
|
Fenethylline (1503)
|
I
|
|
Gamma hydroxybutyric acid (2010)
|
I
|
|
Ibogaine (7260)
|
I
|
|
Lysergic acid diethylamide (7315)
|
I
|
|
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348)
|
I
|
|
Marihuana (7360)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Mescaline (7381)
|
I
|
|
3,4,5-Trimethoxyamphetamine (7390)
|
I
|
|
4-Bromo-2,5-dimethoxyamphetamine (7391)
|
I
|
|
4-Bromo-2,5-dimethoxyphenethylamine (7392)
|
I
|
|
4-Methyl-2,5-dimethoxyamphetamine (7395)
|
I
|
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
3,4-Methylenedioxy-N-ethylamphetamine (7404)
|
I
|
|
3,4-Methylenedioxymethamphetamine (7405)
|
I
|
|
4-Methoxyamphetamine (7411)
|
I
|
|
Alpha-methyltryptamine (7432)
|
I
|
|
Diethyltryptamine (7434)
|
I
|
|
Dimethyltryptamine (7435)
|
I
|
|
Psilocybin (7437)
|
I
|
|
Psilocyn (7438)
|
I
|
|
N-Benzylpiperazine (7493)
|
I
|
|
Etorphine (except HCl)(9056)
|
I
|
|
Heroin (9200)
|
I
|
|
Morphine-N-oxide (9307)
|
I
|
|
Normorphine (9313)
|
I
|
|
Pholcodine (9314)
|
I
|
|
Dextromoramide (9613)
|
I
|
|
Dipipanone (9622)
|
I
|
|
Trimeperidine (9646)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Methylphenidate (1724)
|
II
|
|
Amobarbital (2125)
|
II
|
|
Pentobarbital (2270)
|
II
|
|
Secobarbital (2315)
|
II
|
|
Phencyclidine (7471)
|
II
|
|
Phenylacetone (8501)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Benzoylecgonine (9180)
|
II
|
|
Ethylmorphine (9190)
|
II
|
|
Meperidine (9230)
|
II
|
|
Methadone (9250)
|
II
|
|
Dextropropoxyphene, bulk (non-dosage forms) (9273)
|
II
|
|
Morphine (9300)
|
II
|
|
Oripavine (9330)
|
II
|
|
Thebaine (9333)
|
II
|
|
Levo-alphacetylmethadol (9648)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Poppy Straw Concentrate (9670)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to import small quantities of the listed
controlled substances for the manufacture of analytical
reference standards.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic class of
controlled substance may file comments or objections to the
issuance of the proposed registration and may, at the same time,
file a written request for a hearing on such application
pursuant to 21
CFR 1301.43 and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be
filed no later than January 5, 2009.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b),
(c), (d), (e), and (f). As noted in a previous notice published
in the Federal Register on September 23, 1975, (40 FR 43745),
all applicants for registration to import a basic class of any
controlled substance in schedule I or II are, and will continue
to be, required to demonstrate to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, that the requirements for such registration
pursuant to 21
U.S.C. 958(a); 21
U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: November 26, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E8-28756 Filed 12-4-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
